Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient satisfaction with asthma inhaler devices: pMDI (formoterol/fluticasone propionate) vs Ellipta (vilanterol/fluticasone furoate)
jRCTs041180001Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluticasone propionate + formoterol and fluticasone propionate + vilanterol in asthma (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoint: Overall patient satisfaction with inhaler devices. Started Sep 2018; status: completed.
02
Drugs
fluticasone propionate + formoterolfluticasone propionate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on jRCTs041180001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180001.